Abstract
Developed by THE GERONTOLOGIC SOCIETY OF AMERICASupported by an unrestricted educational grant from AvanirThe prevalence of agitation in Alzheimer’s Disease (AAD) approaches 80%. Patients with AAD have more severe behavioral,depressive, and frontal lobe symptoms and are at increased risk for hospitalization and nursing home placement.Early agitation is a robust predictor of accelerated progression and mortality and is distressing and dangerous for patients and care partners.This presentation was recently developed by the Gerontologic Society of America (GSA) which convened an expert AD Working Group to develop a “Decision Tree” for healthcare providers relative to the assessment of AAD and the employment of Non-Pharmacologic and Pharmacologic treatment options
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
